申请人:KBP Biosciences Co., Ltd.
公开号:EP3750881A1
公开(公告)日:2020-12-16
The present invention provides a novel antibiotic compound represented by the following formula (I), a pharmaceutically acceptable salt thereof, an ester thereof, a prodrug thereof, a solvate thereof, or a deuterated analog thereof, or a stereoisomer thereof. The compound of the present invention exhibits excellent antibacterial activity, especially against Gram bacteria.
wherein each group is defined as in the description.
本发明提供了一种由下式(I)表示的新型抗生素化合物、其药学上可接受的盐、酯、原药、溶液或其氘代类似物或其立体异构体。本发明的化合物具有优异的抗菌活性,特别是对革兰氏细菌。
其中各基团的定义与说明中的相同。